A novel and multifunctional biomarker for cancer

Summary:

A German research team has demonstrated the link between Thrombospondin Type-1 Domain containing 7A Protein and various cancer types and presents a new way to use this tumor specific to improve cancer treatment efficiency by early diagnosis. Sought are industrial or institutional partners involved in the development and/or production of cancer biomarkers, cancer diagnosis/therapy, and research of cancer treatment for licensing, transfer of rights, knowledge transfer, or R&D cooperation.

Reference: TODE20190221001

Country: Germany

Submitted: 2. 9. 2019

View Partnering Opportunity

Keywords

Technology: Applications for Health; Pharmaceutics; Diagnostics, Diagnosis

Market: In-vitro diagnostics; Molecular diagnosis; Therapeutic services

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.